Prevalence of CPK elevation in Patients receiving Biologic Therapies for Atopic Dermatitis: A Systematic Review and Meta-analysis

To systematically quantify the prevalence of CPK elevation in patients with Atopic Dermatitis (AD) who are receiving JAK inhibitors or Dupilumab, and whether there are clinically significant outcomes associated with their use. A PRISMA flow diagram, Funnel plot, Forest plot, ROB Assessment, Search Strategy, PRISMA 2020 checklist and summary table, were created as supplemental figures to be auxiliary to our systematic review and meta-analysis.